Get the Daily Brief
Latest Biotech News
Novel Cancer Therapy Combines Bispecific and ADC Agents to Improve Survival
Roche demonstrated a phase 3 trial success combining the CD20xCD3 bispecific antibody Lunsumio with the antibody-drug conjugate Polivy to treat large B-cell lymphoma (LBCL) patients ineligible for...
Breakthrough AI Biometric Monitoring in Parkinson’s and Biomechanics
Emerging studies leverage AI to enhance medical diagnostics and predictive modeling. One demonstrates that deep learning models incorporating knee alignment significantly improve predictions of...
Advances in Neuroscience: Neural Recording and Brain Function Insights
New high-density neural recording technologies enable brain-wide, real-time monitoring of tens of thousands of neurons in awake primates, providing unprecedented resolution of neural dynamics...
Novel Therapies and Diagnostics in Diabetes and Obesity Management
Recent data highlight progress in diabetes and obesity treatments. Vertex Pharmaceuticals’ cell therapy zimislecel shows promising Phase 1/2 results enabling insulin independence in type 1...
Innovations in Molecular Imaging for Cancer Diagnosis and Treatment Prediction
Cutting-edge molecular imaging agents show promise in improving cancer diagnostics and therapeutic decision-making. Novel immunoPET tracers targeting PD-L1 (^18F-AlF-NOTA-PCP2) and glypican-3...
Climate and Environmental Impacts on Agriculture and Health
Recent studies explore the intersection of climate change, agricultural sustainability, and health. Research on Xinjiang cotton assesses future water footprint variations under climate scenarios,...
Cidara’s CD-388 Flu Drug Shakes Market with Phase IIb Win
San Diego-based biotechnology firm Cidara Therapeutics reported highly positive Phase IIb results for its long-acting antiviral biologic, CD-388, showing strong prevention efficacy against...
Illumina to Acquire SomaLogic, Expanding Proteomics Portfolio
Illumina is set to acquire SomaLogic from Standard BioTools in a deal valued at up to $425 million, including an upfront payment and performance-based milestones and royalties. SomaLogic’s...
FDA Leadership Exodus Continues Amid Regulatory Shifts
The U.S. Food and Drug Administration is experiencing significant leadership turnover as Jacqueline Corrigan-Curay, acting director of the Center for Drug Evaluation and Research (CDER), announced...
Breakthrough in Cancer Chemotherapy Resistance Prediction
Researchers from the Spanish National Cancer Research Centre, in collaboration with the University of Cambridge and Tailor Bio, have developed a novel genomic test capable of predicting...
Novel Oral Drug Candidate Challenges GLP-1 Therapies for Diabetes and Obesity
A promising new oral β2 adrenergic receptor agonist exhibiting GRK-biased signaling emerges as a potential alternative to injectable GLP-1 receptor agonists in treating type 2 diabetes and...
Advances in CAR-T Cell Therapy Targeting Tumor Microenvironment
Recent innovations in chimeric antigen receptor T-cell (CAR-T) therapy are addressing critical limitations in lymphoma treatment by engineering cells capable of overcoming tumor microenvironment...
Robotic and AI Innovations in Airway Management
Emerging technologies in robotic-assisted intubation and artificial intelligence anatomical recognition are revolutionizing airway management in emergency and anesthetic care. Advanced flexible...
Novel PET Tracers Enhance Cancer Detection and Immunotherapy Guidance
Advancements in positron emission tomography (PET) imaging tracers are improving cancer diagnosis and treatment personalization. Newly developed peptide-based tracers targeting immune checkpoint...
AI Chatbots Struggle to Counter Health Misinformation
Recent research highlights significant vulnerabilities in large language models (LLMs) used as AI chatbots, which can be manipulated to disseminate inaccurate and misleading health information....
Robust Advances in Diabetes Cell Therapy from Vertex Pharmaceuticals
Vertex Pharmaceuticals’ pioneering cell therapy for type 1 diabetes, zimislecel, demonstrated promising Phase 1/2 data showing that 10 of 12 patients achieved insulin independence at least one...
Cidara’s CD-388 Floats Ahead in Flu Prevention Race
Cidara Therapeutics announced positive mid-stage Phase 2b data for its long-acting antiviral biologic CD-388, designed to prevent seasonal influenza. The drug demonstrated 76% efficacy in...
FDA Faces Leadership Exodus Amid Regulatory Shifts
The FDA is undergoing significant senior leadership turnover, intensifying industry and market uncertainty. Jacqueline Corrigan-Curay, acting director of the Center for Drug Evaluation and...
Illumina Bolsters Proteomics With SomaLogic Acquisition
Genomic sequencing leader Illumina has agreed to acquire proteomics firm SomaLogic from Standard BioTools for up to $425 million. The acquisition enhances Illumina’s multiomics portfolio by...
Advances in GLP-1 and Obesity Therapeutics Shake Market
New clinical findings at ADA 2025 highlight continued innovation and competition in obesity and diabetes treatments centered on GLP-1 receptor agonists. Amgen’s obesity drug MariTide showed...